I. By Edwards
The termination of off -brand weight loss and diabetes drugs of diabetes drugs is currently applied to block access to the drugs that many patients contain.
CNN has declared that the US Food and Drug Administration (FDA) has ended the shortage of popular GLP-1 drugs. Such drugs include Semaglutide (Ozempic and Wegovy) and Tirzepatide (Mounjaro and Zepbound).
This means that it is no longer legally producing or selling the composite version of these drugs made by small pharmacies and sold without FDA approval.
The deadline for stopping the production and distribution of the complex Tiri discipleship was passed in March. Thursday was the last day of the complex semagluide.
For thousands of people, this complex was cheaper than the brand version. According to Josh Fritzler’s chief financial officer, only Olympia Pharm has supplied more than 70,000 people every week.
“We had to be transparent.
Michelle Pierce, a 25 -year -old Texas, said that the composite semi glute has helped to lower blood sugar and avoid back surgery. But at the end of availability, she told CNN, “There is no different option. I can’t afford to pay completely in my pocket.”
But some doctors are worried about the safety of the complex version.
“I don’t know what’s in this compound. I don’t know about purity. I don’t know about drug interactions. I don’t know about drug interactions. I don’t know about drug interactions.” “I really don’t want to be responsible for it.”
She does not support the use of a composite GLP-1, but Dushay predicts that new restrictions can strain the supply of drugs, especially initial doses.
The FDA says pharmaceutical companies have enough manufacturing capabilities to meet the current and expected demand, CNN said.
Novo Nordisk is convinced of the supply of Semaglutide, CNN said. Meanwhile, ELI LILLY, a manufacturer of Tirzepatide, warned that unlasted knock -offs could be dangerous.
The company’s statement said, “The person who continues to sell mass compound Tirzepatide, including ‘personalized’, ‘customized’ or similar to it, is in danger of making a law.
In order to improve access, both companies started their online platform and started providing single dose vials. Nevertheless, many patients face steep costs and limited insurance coverage.
“The tribe is much better. The scope of insurance is much worse.”
Lee Rosebush is the chairman of the Outsourcing Facility Association, which represents a large -scale complex pharmacy. He said that his trade group filed a lawsuit to challenge the FDA’s decision to remove the drug from the list of tribes. I lost both cases.
Rosebush told CNN, “What happens when the deadline occurs at the end of this week is not accessible to the drugs that the patient and the provider needs, which will be financially affected when moving forward.
Pierce, a Texas patient, said he had six months of medication, but others were worried.
She is starting a complex medicine that doesn’t know that some people can’t quickly access complex medicine, she said.
Additional information:
Brown University Health has more Complex weight loss drug.
© 2025 Healthy day. All rights holdings.
recall: FDA has stopped selling off-brands Ozempic and other GLP-1 drugs (2025, May 23), May 25, 2025
This document is copyrighted. In addition to fair transactions for individual research or research purposes, no part can be reproduced without written permission. The contents are provided only for information purposes.
